News

A study found when ribociclib, a targeted therapy drug, is added to hormone therapy there are a significant invasive disease-free survival benefit in patients with early hormone-receptor (HR) positive/HER2 negative breast cancer.

Results of a trial of pirtobrutinib highlight the drug’s impact and potential for pre-treated mantle cell lymphomas.

Clinical trial suggests low-dose atropine is effective myopia treatment.

Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.

Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria’s metabolism.

Scientists at the North Carolina State University found that a chemical compound produced through the digestion of a common artificial sweetener causes damage to DNA.

Researchers add another powerful tool to their “molecular editing” kit for crafting pharmaceuticals and other valuable compounds, enabling chemists to add new elements to organic molecules at locations that were previously out of reach.

A brightly colored microcrystal that loses its color over time depending on temperature could be used to identify whether a vial of medicine has gotten too warm.

Scientists have discovered a novel approach that improves the efficacy of immune checkpoint inhibitor cancer treatment and minimizes the associated side effects.

The genetic variants that cause a rare and inflammatory skin condition have been identified, alongside a potential treatment.